Deregulation of the Rb and p53 pathways in uveal melanoma.
about
Oncogenic mutations in GNAQ occur early in uveal melanomaMetastatic disease from uveal melanoma: treatment options and future prospectsThe genetics of uveal melanoma: current insightsGene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic deathProteomics in uveal melanoma research: opportunities and challenges in biomarker discoveryMelanoma epidemiology, biology and prognosis.The genetics of uveal melanoma: an emerging framework for targeted therapyPERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells.Eye cancer: unique insights into oncogenesis: the Cogan Lecture.Analysis of Bcl-2 protein expression in choroidal melanomasMolecular prognostic testing and individualized patient care in uveal melanoma.A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma.Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.Suppression of thrombospondin-1 expression during uveal melanoma progression and its potential therapeutic utility.High levels of Hdmx promote cell growth in a subset of uveal melanomas.Genomic investigations of posterior uveal melanoma.Molecular pathology of uveal melanomaClass III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanomaMalignant melanoma in the 21st century: the emerging molecular landscape.Emerging insights into the molecular pathogenesis of uveal melanoma.p63 is required beside p53 for PERP-mediated apoptosis in uveal melanoma.Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.Minimal contribution of ERK1/2-MAPK signalling towards the maintenance of oncogenic GNAQQ209P-driven uveal melanomas in zebrafishGenetics of uveal melanoma and cutaneous melanoma: two of a kind?Insights into melanoma: targeting the mTOR pathway for therapeutics.A review of advanced genetic testing for clinical prognostication in uveal melanoma.Genetic determinants of uveal melanoma.Focus on cutaneous and uveal melanoma specificities.Uveal melanoma.Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma.Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis.Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma.P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma.Germline mutation in the TP53 gene in uveal melanoma.p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours.
P2860
Q24658558-8EE47CDF-7D5A-440B-9639-B5AD3F1069F9Q26738377-AF502C69-096F-4FF7-8E07-6CCEF34E6C1CQ28073150-D60E842C-4F6B-4E41-B89E-FC945D24884FQ28288495-8BEE3D7D-CF3C-43F5-A5EB-4008BB6D1212Q28297411-B3080254-2438-4530-8846-1E86B624D0E6Q33698718-B0129D12-09B6-4113-AE45-91BAC48AE956Q34249080-DBB5F201-E4BC-4341-9FA6-47C321100C48Q35006415-FAFD2951-42E6-428E-8B4C-34A55938997AQ35585887-2AF34E46-74A2-4360-8EC0-3A4504405CFDQ35588563-9879C5F0-902C-497E-B3AB-61393D89A2A9Q35750425-77D0C6DC-8340-4157-900A-9F0FD3A0C82AQ35823432-7E43086F-1444-419A-9E13-843C6B9F95B1Q35904981-A41BCE66-AD44-40C1-8799-33523595621DQ36054784-2A17CEB5-6F9C-4E86-B86D-43A90F5BA441Q36206473-690E867C-7F92-45F8-862E-7B5F27F6BC88Q36341133-240F8287-37C8-49B3-AC59-9934D77D911BQ36615059-0FF08790-9D8D-47CA-BFDD-FAA5655C6F84Q36651002-0CF5B6A0-C612-457C-BDFA-81E1A467863DQ37211362-349F2C8B-6C80-4039-8B74-669940DF5720Q37298647-F1E7777C-7D6D-4EAA-9F4A-6113CC942CEBQ37335116-0B50DE27-DC23-4B54-B1CF-1669DF41B581Q37422728-C1C617F8-BFA1-454B-9AD9-9A185198B50CQ37457622-13D47043-19DA-4A3A-BA6B-0886A0491413Q37772777-1E247E58-87F4-4322-9ECF-62A4CBB05E37Q38012466-56F959EA-A414-439C-8400-5BFCCAE13E1AQ38134805-BC2943B7-5D4B-40B5-A706-B6B8496079D1Q38258203-54E6FA8B-3265-41B1-8632-E47D8190898CQ39312161-1AC4FCAE-FFF3-4A0F-9501-20E6BE3F1DBCQ39726923-79E885A8-DD22-4F19-AD55-CE504C2B3509Q41609825-10C042CA-A6FF-4770-80B7-E84C544C0176Q44489695-342DA14C-6C71-49B3-A65F-9BE8FDE5C437Q45122606-08A73CB2-9FA3-4D08-BD38-C33149432C42Q45345454-1D0B1A9E-A354-428B-AEE8-01A6CF182F9FQ53831563-654F530A-F65A-4282-A637-A0E9530F3D21Q54672464-6995C19E-A811-430D-AFBF-E1EEB605BB29
P2860
Deregulation of the Rb and p53 pathways in uveal melanoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Deregulation of the Rb and p53 pathways in uveal melanoma.
@ast
Deregulation of the Rb and p53 pathways in uveal melanoma.
@en
type
label
Deregulation of the Rb and p53 pathways in uveal melanoma.
@ast
Deregulation of the Rb and p53 pathways in uveal melanoma.
@en
prefLabel
Deregulation of the Rb and p53 pathways in uveal melanoma.
@ast
Deregulation of the Rb and p53 pathways in uveal melanoma.
@en
P2860
P1476
Deregulation of the Rb and p53 pathways in uveal melanoma.
@en
P2093
J W Harbour
M A Brantley
P2860
P304
P356
10.1016/S0002-9440(10)64817-1
P407
P577
2000-12-01T00:00:00Z